Hospital Universitario Donostia

San Sebastián, Guipuzcoa 20014

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Completed